HMOX1 and breast cancer: The patented traditional Chinese medicine, Shuganning injection, could selectively upregulate heme oxygenase 1 (HO-1) expression in TNBC cells, leading to lipid iron pool accumulation and ferroptosis occurrence, inhibiting breast cancer tissue growth both in vivo and in vitro (95).